Skip to main content

Omidria FDA Approval History

FDA Approved: Yes (First approved May 30, 2014)
Brand name: Omidria
Generic name: ketorolac and phenylephrine
Dosage form: Injection
Company: Omeros Corporation
Treatment for: Intraocular Lens Replacement Procedures

Omidria (ketorolac and phenylephrine) is an anti-inflammatory and mydriatic combination added to irrigation solution during cataract surgery and intraocular lens replacement procedures.

Development timeline for Omidria

Dec 12, 2017Approval Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients
Jun  2, 2014Approval FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.